Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis

Department of Cellular & Molecular Medicine, St George's University of London, London, UK.
Journal of General Virology (Impact Factor: 3.53). 12/2009; 91(Pt 4):893-7. DOI: 10.1099/vir.0.017590-0
Source: PubMed

ABSTRACT Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a neuro-immune disease of uncertain pathogenesis. Human parvovirus B19 infection has been shown to occur just prior to development of the onset of CFS/ME in several cases, although B19 seroprevalence studies do not show any significant differences between CFS/ME and controls. In this study, we analysed parvovirus B19 markers in CFS/ME patients (n=200), diagnosed according to Fukuda CDC criteria, and normal blood donors (n=200). Serum from each subject was tested for anti-B19 VP2 IgM and IgG (by Biotrin ELISA), anti-B19 NS1 IgM and IgG (by immunofluorescence), and B19 DNA (by real-time PCR). CFS/ME patients and normal blood donors had a similar B19 seroprevalence (75 % versus 78 %, respectively). Eighty-three CFS patients (41.5 %) as compared with fourteen (7 %) normal blood donors tested positive for anti-B19 NS1 IgG (chi(2)=64.8; P<0.0001; odds ratio=9.42, CI 5.11-17.38). Of these 83 patients, 61 complained of chronic joint pain, while 22 did not. Parvovirus B19 DNA was detected in serum of 11 CFS patients and none of the controls by Taqman real-time PCR (chi(2)=9.35, P<0.002). Positivity for anti-B19 NS1 IgG was associated with higher expression levels of the human CFS-associated genes NHLH1 and GABPA. As NS1 antibodies are thought to indicate chronic or severe courses of B19 infection, these findings suggest that although the seroprevalence of B19 in CFS patients is similar to controls, the immune control of the virus in these patients may not be efficient.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Discussed the development of commercial GaAs ICs for high speed, 6-bit, 1 Gsample/s data acquisition, using a low-cost conventional D-MESFET technology. First-generation S/Hs (sample-and-holds) and comparators are considered. Diode-bridge and FET-switch S/Hs are compared; best performances have been achieved with diode-bridge switches: 1 ns, 6-bit. Comparators provide 6-bit sensitivity at 1 GHz, but require offset adjust. Second-generation ADC (analog-to-digital converters) building blocks are also discussed. The auto biased differential input stage has been developed which is suitable for 4-bit ADC. A dynamic cell involving autocalibration techniques is required for 6-bit ADC. Using these blocks, a 4-bit 1-Gs/s full Nyquist single-ship ADC, including an S/H, has been designed. A 6-bit ADC is under design
    Custom Integrated Circuits Conference, 1988., Proceedings of the IEEE 1988; 06/1988
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Last century there was a short burst of interest in the tryptophan related disorders of pellagra and related abnormalities that are usually presented in infancy.1,2 Nutritional physiologists recognized that a severe human dietary deficiency of either tryptophan or the B group vitamins could result in central nervous system (CNS) sequelae such as ataxia, cognitive dysfunction and dysphoria, accompanied by skin hyperpigmentation.3,4 The current paper will focus on the emerging role of tryptophan in chronic fatigue syndrome (CFS) and fibromyalgia (FM).
    International Journal of Tryptophan Research 09/2012; 5:27-32. DOI:10.4137/IJTR.S10085
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: It is of importance whether myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a variant of sickness behavior. The latter is induced by acute infections/injury being principally mediated through proinflammatory cytokines. Sickness is a beneficial behavioral response that serves to enhance recovery, conserves energy and plays a role in the resolution of inflammation. There are behavioral/symptomatic similarities (for example, fatigue, malaise, hyperalgesia) and dissimilarities (gastrointestinal symptoms, anorexia and weight loss) between sickness and ME/CFS. While sickness is an adaptive response induced by proinflammatory cytokines, ME/CFS is a chronic, disabling disorder, where the pathophysiology is related to activation of immunoinflammatory and oxidative pathways and autoimmune responses. While sickness behavior is a state of energy conservation, which plays a role in combating pathogens, ME/CFS is a chronic disease underpinned by a state of energy depletion. While sickness is an acute response to infection/injury, the trigger factors in ME/CFS are less well defined and encompass acute and chronic infections, as well as inflammatory or autoimmune diseases. It is concluded that sickness behavior and ME/CFS are two different conditions.
    BMC Medicine 03/2013; 11(1):64. DOI:10.1186/1741-7015-11-64
Show more